Biovest International Inc (BVTI) financial statements (2020 and earlier)

Company profile

Business Address 324 S HYDE PARK AVE
TAMPA, FL 33606
State of Incorp. DE
Fiscal Year End September 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments734
Cash and cash equivalents734
Receivables530
Inventory, net of allowances, customer advances and progress billings329
Inventory329
Costs in excess of billings240
Other undisclosed current assets208
Total current assets:2,041
Noncurrent Assets
Property, plant and equipment1,391
Intangible assets, net (including goodwill)39,697
Goodwill3,897
Intangible assets, net (excluding goodwill)35,800
Other noncurrent assets516
Other undisclosed noncurrent assets(21)
Total noncurrent assets:41,583
TOTAL ASSETS:43,624
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,100
Accounts payable754
Accrued liabilities346
Debt147
Other undisclosed current liabilities4
Total current liabilities:1,251
Noncurrent Liabilities
Long-term debt and lease obligation391
Long-term debt, excluding current maturities305
Capital lease obligations86
Liabilities, other than long-term debt10
Other liabilities10
Total noncurrent liabilities:401
Total liabilities:1,652
Stockholders' equity
Stockholders' equity attributable to parent41,972
Common stock1,000
Additional paid in capital42,449
Accumulated deficit(1,477)
Total stockholders' equity:41,972
TOTAL LIABILITIES AND EQUITY:43,624

Income statement (P&L) ($ in thousands)

9/30/2013
Gross profit:(1,000)
Operating loss:(1,000)
Net loss available to common stockholders, diluted:(1,000)

Comprehensive Income ($ in thousands)

9/30/2013
Net loss:(1,000)
Comprehensive loss, net of tax, attributable to parent:(1,000)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: